Scott Dylla is a Scientific Advisor at Notable Labs. Scott has also previously worked as a Vice President of Research & Development and Chief Scientific Officer at AbbVie Stemcentrx, LLC, a Co-Founder & Chief Scientific Officer at Stemcentrx, Inc., and a Sr. Scientist at OncoMed Pharmaceuticals. Prior to that, they were a Postdoctoral Scholar at Stanford University School of Medicine.
Scott Dylla has a Ph.D in Cancer Biology & Immunology from the University of Minnesota, an M.S. in Molecular & Cellular Pathobiology from the University of Alabama at Birmingham, and a B.S. in Biochemistry & Molecular Biology from the University of Minnesota Duluth.
This person is not in the org chart